This session explored why, how, and when to meaningfully engage patients and communities across the trial lifecycle for effective clinical research. Speakers shared best practices for engagement from across the continent, highlighted successful models such as Community Advisory Boards, and unpacked how stakeholders—including industry, regulators, civil society, and researchers – can build trust and co-create research agendas.
Rewatch the sessions below. You can download the full presentation here.
